vs
ACACIA RESEARCH CORP（ACTG）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ACACIA RESEARCH CORP的1.5倍（$75.5M vs $50.1M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 2.6%），过去两年ACACIA RESEARCH CORP的营收复合增速更高（43.6% vs 31.3%）
槐亚研究公司是一家总部位于纽约市的美国上市企业，在科技、能源以及工业制造领域开展业务收购与运营工作。该公司与控股股东斯塔博德价值投资合伙企业保持战略伙伴关系，这家企业在业内常被归类为专利流氓。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ACTG vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.5倍
$50.1M
营收增速更快
PBYI
高出25.1%
2.6%
两年增速更快
ACTG
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $50.1M | $75.5M |
| 净利润 | $3.4M | — |
| 毛利率 | 12.8% | 69.3% |
| 营业利润率 | -26.1% | 22.7% |
| 净利率 | 6.8% | — |
| 营收同比 | 2.6% | 27.7% |
| 净利润同比 | 125.5% | — |
| 每股收益（稀释后） | $0.03 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTGPBYI
| Q4 25 | $50.1M | $75.5M | ||
| Q3 25 | $59.4M | $54.5M | ||
| Q2 25 | $51.2M | $52.4M | ||
| Q1 25 | $124.4M | $46.0M | ||
| Q4 24 | $48.8M | $59.1M | ||
| Q3 24 | $23.3M | $80.5M | ||
| Q2 24 | $25.8M | $47.1M | ||
| Q1 24 | $24.3M | $43.8M |
净利润ACTGPBYI
| Q4 25 | $3.4M | — | ||
| Q3 25 | $-2.7M | $8.8M | ||
| Q2 25 | $-3.3M | $5.9M | ||
| Q1 25 | $24.3M | $3.0M | ||
| Q4 24 | $-13.4M | — | ||
| Q3 24 | $-14.0M | $20.3M | ||
| Q2 24 | $-8.4M | $-4.5M | ||
| Q1 24 | $-186.0K | $-4.8M |
毛利率ACTGPBYI
| Q4 25 | 12.8% | 69.3% | ||
| Q3 25 | 21.2% | 77.7% | ||
| Q2 25 | 12.8% | 76.5% | ||
| Q1 25 | 47.4% | 77.1% | ||
| Q4 24 | 17.6% | 76.4% | ||
| Q3 24 | 10.1% | 63.9% | ||
| Q2 24 | 26.2% | 77.4% | ||
| Q1 24 | 49.2% | 75.5% |
营业利润率ACTGPBYI
| Q4 25 | -26.1% | 22.7% | ||
| Q3 25 | -10.8% | 17.6% | ||
| Q2 25 | -24.2% | 12.7% | ||
| Q1 25 | 30.8% | 8.7% | ||
| Q4 24 | -32.4% | 22.6% | ||
| Q3 24 | -44.1% | 27.4% | ||
| Q2 24 | -18.4% | -4.6% | ||
| Q1 24 | -8.6% | -5.3% |
净利率ACTGPBYI
| Q4 25 | 6.8% | — | ||
| Q3 25 | -4.6% | 16.2% | ||
| Q2 25 | -6.4% | 11.2% | ||
| Q1 25 | 19.5% | 6.5% | ||
| Q4 24 | -27.5% | — | ||
| Q3 24 | -60.0% | 25.2% | ||
| Q2 24 | -32.7% | -9.6% | ||
| Q1 24 | -0.8% | -11.0% |
每股收益（稀释后）ACTGPBYI
| Q4 25 | $0.03 | $0.26 | ||
| Q3 25 | $-0.03 | $0.17 | ||
| Q2 25 | $-0.03 | $0.12 | ||
| Q1 25 | $0.25 | $0.06 | ||
| Q4 24 | $-0.14 | $0.40 | ||
| Q3 24 | $-0.14 | $0.41 | ||
| Q2 24 | $-0.08 | $-0.09 | ||
| Q1 24 | $0.00 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.7M | $97.5M |
| 总债务越低越好 | $91.9M | $22.7M |
| 股东权益账面价值 | $543.5M | $130.3M |
| 总资产 | $771.0M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ACTGPBYI
| Q4 25 | $306.7M | $97.5M | ||
| Q3 25 | $301.8M | $94.4M | ||
| Q2 25 | $316.7M | $96.0M | ||
| Q1 25 | $272.0M | $93.2M | ||
| Q4 24 | $273.9M | $101.0M | ||
| Q3 24 | $410.9M | $96.7M | ||
| Q2 24 | $441.9M | $96.8M | ||
| Q1 24 | $498.4M | $107.2M |
总债务ACTGPBYI
| Q4 25 | $91.9M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ACTGPBYI
| Q4 25 | $543.5M | $130.3M | ||
| Q3 25 | $537.6M | $115.3M | ||
| Q2 25 | $538.6M | $104.7M | ||
| Q1 25 | $540.2M | $97.1M | ||
| Q4 24 | $514.8M | $92.1M | ||
| Q3 24 | $540.2M | $71.1M | ||
| Q2 24 | $560.7M | $48.5M | ||
| Q1 24 | $568.3M | $51.0M |
总资产ACTGPBYI
| Q4 25 | $771.0M | $216.3M | ||
| Q3 25 | $768.9M | $202.9M | ||
| Q2 25 | $775.5M | $194.9M | ||
| Q1 25 | $801.6M | $196.2M | ||
| Q4 24 | $756.4M | $213.3M | ||
| Q3 24 | $707.6M | $220.7M | ||
| Q2 24 | $753.6M | $205.0M | ||
| Q1 24 | $631.7M | $214.1M |
负债/权益比ACTGPBYI
| Q4 25 | 0.17× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 22.01× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ACTGPBYI
| Q4 25 | $75.2M | $14.4M | ||
| Q3 25 | $9.5M | $9.7M | ||
| Q2 25 | $50.1M | $14.1M | ||
| Q1 25 | $2.4M | $3.6M | ||
| Q4 24 | $50.1M | $15.6M | ||
| Q3 24 | $-593.0K | $11.0M | ||
| Q2 24 | $16.1M | $1.0M | ||
| Q1 24 | $54.8M | $11.2M |
自由现金流ACTGPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | $335.0K | $3.6M | ||
| Q4 24 | $-98.5M | $15.6M | ||
| Q3 24 | $-2.8M | $11.0M | ||
| Q2 24 | $-126.7M | $1.0M | ||
| Q1 24 | $54.6M | — |
自由现金流率ACTGPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | 0.3% | 7.7% | ||
| Q4 24 | -201.8% | 26.4% | ||
| Q3 24 | -12.1% | 13.7% | ||
| Q2 24 | -490.5% | 2.1% | ||
| Q1 24 | 224.4% | — |
资本支出强度ACTGPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 1.7% | 0.1% | ||
| Q4 24 | 304.4% | 0.0% | ||
| Q3 24 | 9.6% | 0.0% | ||
| Q2 24 | 553.0% | 0.0% | ||
| Q1 24 | 1.1% | 0.0% |
现金转化率ACTGPBYI
| Q4 25 | 22.01× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | 0.10× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACTG
| Energy Operations | $16.0M | 32% |
| Transportation Safety | $10.4M | 21% |
| Office Storage And Display Solutions | $8.4M | 17% |
| Printers Consumables And Parts | $6.5M | 13% |
| Natural Gas Reserves | $5.1M | 10% |
| Natural Gas Liquids Reserves | $3.3M | 7% |
PBYI
暂无分部数据
